Journal
LANCET
Volume 376, Issue 9743, Pages 803-813Publisher
ELSEVIER SCIENCE INC
DOI: 10.1016/S0140-6736(10)61087-2
Keywords
-
Categories
Funding
- NHMRC
- AstraZeneca
- Boehringer Ingelheim
- GlaxoSmithKline
- Novartis
- Pharmaxis
- National Health and Medical Research Council (NHMRC) Centre for Respiratory and Sleep Medicine
- Australian Department of Health and Ageing through the Australian Institute of Health and Welfare
Ask authors/readers for more resources
Asthma in older people is common and is characterised by underdiagnosis and undertreatment. Ageing is associated with unique issues that modify expression, recognition, and treatment of the disease. In particular, asthma and chronic obstructive pulmonary disease (COPD) both overlap and converge in older people. This concurrence, together with absence of precise diagnostic methods, makes diagnosis complex. A multidimensional assessment that addresses airway problems, comorbidities, risk factors, and management skills will draw attention to key needs for intervention. Increased attention to the complications of asthma and obstructive airway disease in older people is needed, specifically to develop effective systems of care, appropriate clinical practice guidelines, and a research agenda that delivers improved health outcomes.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available